Precision Medicine News and Research

RSS

Promising radioisotope couple for cancer diagnosis and therapy

Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics — a diagnosis-and-treatment approach based on the combination of medical imaging and internal radiation therapy with radioactive elements.

9 May 2019

Study could lead to improved diagnosis and treatment of ovarian cancer

Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.

8 May 2019

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.

6 May 2019

Biomarker may help predict first treatment option for metastatic colorectal cancer patients

Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option.

2 May 2019

Researchers use 3D printer to make paper organs

Long before scientists test new medicines in animals or people, they study the effects of the substances on cells growing in Petri dishes.

1 May 2019

Multigene test helps doctors to make effective treatment decisions for breast cancer patients

A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.

30 Apr 2019

Precision medicine for pediatric tumors can now be a reality, shows study

Five years after it was created to serve children and adolescents in Quebec, the TRICEPS team at CHU Sainte-Justice has demonstrated the feasibility of setting up a research program in pediatric oncology precision medicine, as described in a recent article published in the JAMA Network Open journal.

30 Apr 2019

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

An EU-funded project has developed a blood-cell analysis device that helps doctors and scientists better understand the causes and mechanics of rare forms of anemia - potentially speeding up the development of new treatments adjusted to the needs of patients with these diseases.

25 Apr 2019

Blood test can help match cancer patients to early phase clinical trials

Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines, by analyzing the genetic faults in a sample of their blood, according to research published in Nature Medicine today (Monday).

23 Apr 2019

Treating cancer patients with personalized, combination therapies improves outcomes

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.

23 Apr 2019

Scientists deploy CRISPR gene-editing tool to engineer multiple edits

Scientists at Christiana Care Health System's Gene Editing Institute and NovellusDx, an Israeli biotechnology company, have deployed a breakthrough CRISPR gene-editing tool to successfully engineer multiple edits simultaneously to fragments of DNA extracted from a human cell, according to a new study published today in The CRISPR Journal.

19 Apr 2019

Online atlas created to identify, classify protein signatures present at AML diagnosis

Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis.

17 Apr 2019

Study uncovers new biomarker for personalized cancer treatments

Cancer cells are characterized by the ability to evade apoptosis, a type of programmed cell death that allows the organism to remove damaged cells.

16 Apr 2019

Statins provide no benefit for 50 percent of patients, say researchers

Millions of patients do not benefit from taking statins and fail to achieve a cholesterol level low enough to reduce their risk of heart or stroke, report researchers.

16 Apr 2019

Precise decoding of breast cancer cells paves way for new treatment option

Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors.

16 Apr 2019

Neuronal transport factor detects its target transcripts in more complex manner than previously thought

A team of scientists from Helmholtz Zentrum München and the University of Ulm has discovered that the neuronal transport factor Staufen2 scans and binds to its target transcripts in a much more complex manner than previously thought.

16 Apr 2019

Discovery of biomarkers could lead to new, better treatment options for heart disease

Coronary heart disease is a leading cause of death worldwide, but identifying those at high risk remains difficult. EU-funded research has helped identify new biomarkers that will improve diagnosis and lead to new and better treatment options.

12 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth.

12 Apr 2019

Large-scale screen efficiently identifies drugs that are potent cancer-killers

UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone.

10 Apr 2019

Precision Medicine News and Research

Promising radioisotope couple for cancer diagnosis and therapy

Study could lead to improved diagnosis and treatment of ovarian cancer

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

Biomarker may help predict first treatment option for metastatic colorectal cancer patients

Researchers use 3D printer to make paper organs

Multigene test helps doctors to make effective treatment decisions for breast cancer patients

Precision medicine for pediatric tumors can now be a reality, shows study

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

Blood test can help match cancer patients to early phase clinical trials

Treating cancer patients with personalized, combination therapies improves outcomes

Scientists deploy CRISPR gene-editing tool to engineer multiple edits

Online atlas created to identify, classify protein signatures present at AML diagnosis

Study uncovers new biomarker for personalized cancer treatments

Statins provide no benefit for 50 percent of patients, say researchers

Precise decoding of breast cancer cells paves way for new treatment option

Neuronal transport factor detects its target transcripts in more complex manner than previously thought

Discovery of biomarkers could lead to new, better treatment options for heart disease

FDA approves new treatment for adults with metastatic bladder cancer

Study describes vulnerability shared by large subset of cancer cell lines

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News